Septerna Quarterly Balance Sheet
NASDAQ: SEPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Septerna financial position
As of Jun 30, 2026, Septerna reported total assets of $566.7 million, up 36.5% from a year earlier against total liabilities of $180.0 million. Shareholders' equity stood at $386.7 million, or 68.2% of assets. The company held $84.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.99, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Septerna balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 84.66M | 71.61M | 120.72M | 319.99M | 189.31M | 210.04M | 238.20M | 88.24M | 131.17M | 81.34M | 88.48M | 98.52M |
| Short-Term Investments | 287.66M | 275.80M | 270.37M | 154.36M | 137.25M | 125.96M | 112.73M | 42.29M | — | — | 0 | — |
| Receivables | 12.16M | 10.84M | 10.36M | 8.64M | 151.00K | 250.00K | 171.00K | 210.00K | — | — | 151.00K | — |
| Total Current Assets | 396.15M | 368.06M | 410.96M | 491.68M | 334.14M | 342.47M | 356.82M | 133.41M | — | — | 112.68M | — |
| Property, Plant & Equipment | 3.90M | 4.33M | 4.43M | 4.32M | 4.69M | 5.04M | 5.09M | 5.41M | — | — | 4.67M | — |
| Long-Term Investments | 144.19M | 174.69M | 157.57M | 87.21M | 52.63M | 62.24M | 69.87M | 6.98M | — | — | 0 | — |
| Total Assets | 566.74M | 569.69M | 596.19M | 606.65M | 415.23M | 434.02M | 456.55M | 174.28M | — | — | 130.87M | — |
| Accounts Payable | 3.97M | 7.46M | 10.28M | 3.73M | 6.54M | 4.35M | 3.20M | 6.13M | — | — | 2.64M | — |
| Total Current Liabilities | 79.32M | 78.17M | 86.93M | 75.28M | 15.13M | 10.64M | 12.85M | 13.23M | — | — | 6.91M | — |
| Total Liabilities | 180.02M | 191.23M | 214.26M | 217.92M | 37.67M | 33.75M | 36.51M | 37.53M | — | — | 20.03M | — |
| Shareholders' Equity | 386.72M | 378.46M | 381.93M | 388.73M | 377.56M | 400.27M | 420.05M | -87.41M | -67.76M | -51.89M | -38.37M | -73.85M |
| Retained Earnings | -188.92M | -175.89M | -167.25M | -156.51M | -164.69M | -139.85M | -118.37M | -97.71M | — | — | -46.58M | — |
| Net Cash (Debt) | 372.32M | 347.40M | 391.09M | 474.35M | 326.56M | 336.00M | 350.92M | 130.53M | 131.17M | 81.34M | 88.48M | 98.52M |
| Shares Outstanding | 45.67M | 44.92M | 44.81M | 44.64M | 44.57M | 44.45M | 44.42M | — | — | — | 3.17M | — |
This table shows 12 quarterly periods of Septerna's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SEPN's reporting calendar. What is a balance sheet?